|
 |
Levonorgestrel and Ethinyl EstradiolThis page contains recent news articles, when available, and an overview of Levonorgestrel and Ethinyl Estradiol but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.AG200-15 is also based on Agile's patented SKINFUSION™ technology, and utilizes the trusted hormonal combination of levonorgestrel and ethinyl estradiol. PR-USA.net (press release) Agile Therapeutics Abstracts on Lead Product, AG200-15 Accepted by ... - Dec 9, 2008 The two abstracts scheduled for poster presentation are: (1) Pharmacokinetics: Contraceptive Patches Containing Levonorgestrel and Ethinyl Estradiol vs. Earthtimes (press release), Agile Therapeutics Announces Issuance of Key Patents for Its ... - Oct 28, 2008 SKINFUSION(TM) technology makes it possible to utilize the trusted hormone combination of levonorgestrel and ethinyl estradiol in a contraceptive patch. MarketWatch Agile's Lead Product, AG200-15,Moving Into Pivotal Phase 3 Trials - Nov 18, 2008 While citing no safety concerns over drug components, levonorgestrel and ethinyl estradiol, the FDA is requiring the customary birth control Phase 3 study PipelineReview.com (press release), Agile Therapeutics Announces Issuance of Key Patents for Its ... - Oct 28, 2008 SKINFUSION™ technology makes it possible to utilizethe trusted hormone combination of levonorgestrel and ethinyl estradiol ina contraceptive patch. International Business Times, Paladin Labs and Procter & Gamble Pharmaceuticals Enter Into ... - 03 Jul 2008 SEASONALE TM (levonorgestrel and ethinyl estradiol 0.15mg/0.03 mg tablets) is an effective new contraceptive option for Canadian women, striking a balance Market Wire (press release) Paladin Reports 2008 First Quarter Financial Results - May 15, 2008 Seasonale(TM) (levonorgestrel and ethinyl estradiol 0.15mg/0.03mg tablets) is a safe and effective contraceptive option for women, striking a balance Earthtimes (press release), Watson Pharmaceuticals Inc files application for levonorgestrel ... - Mar 5, 2008 Drug Administration (FDA) for the marketing approval for its levonorgestrel and ethinyl estradiol (0.15 mg/0.03 mg) extended-cycle oral contraceptive Trading Markets (press release), Watson Files Application for Generic SEASONIQUE(R) - Mar 4, 2008 Inc., a subsidiary of Barr Pharmaceuticals, Inc. Watson's levonorgestrel and ethinyl estradiol product is a generic version of Barr's SEASONIQUE(R). PR Newswire (press release), Watson Files Application For Generic Seasonique - Quick Facts [WPI] - Mar 4, 2008 ...and Drug Administration seeking approval to market its levonorgestrel and ethinyl estradiol (0.15 mg/0.03 mg) extended-cycle oral contraceptive product, RTT News, Watson files application for generic contraceptive drug - Mar 5, 2008 Watson's levonorgestrel and ethinyl estradiol product is a generic version of Barr's Seasonique. On January 23, 2008, Watson has notified Barr that it had Trading Markets (press release), Market Report -- In Play (WPI) - Mar 4, 2008 Watson's levonorgestrel and ethinyl estradiol product is a generic version of Barr's SEASONIQUE. Briefing.com is the leading Internet provider of live MSN Money Paladin Reports Record 2007 Fourth Quarter and Year End Results - Feb 28, 2008 Seasonale(TM), (levonorgestrel and ethinyl estradiol 0.15mg/0.03mg tablets), is a safe and effective contraceptive option for women, striking a balance Web Services Journal, Is it safe to have no menstrual cycle with birth control pills - Nov 13, 2007 US Food & Drug Administration (FDA) has approved Lybrel (levonorgestrel and ethinyl estradiol) on May 22, 2007, which is the first low-dose combination oral PR-USA.net (press release), Paladin Reports 2007 Record Third Quarter Financial Results - Nov 1, 2007 Seasonale TM , (levonorgestrel and ethinyl estradiol 0.15mg/0.03 mg tablets), is a safe and effective contraceptive option for woman, striking a balance Market Wire (press release) Sperm stopped in their tracks by vaginal gel contraceptive - Oct 3, 2007 Meanwhile, Wyeth received US approval earlier this year for the contraceptive pill Lybrel (levonorgestrel and ethinyl estradiol), which taken every day not DrugResearcher.com, Thomson Scientific Publishes The Ones to Watch - A Quarterly ... - Aug 16, 2007 Second on our list is Wyeth, which is marketing Lybrel(TM) -- a combination of Levonorgestrel and ethinyl estradiol in a daily oral tablet which eliminates CNNMoney.com Barr Gets Canadian Approval for Generic Oral Contraceptive - Aug 28, 2007 ...oral contraceptive marketed by Duramed Pharmaceuticals Inc. Nordette has the same active ingredients as Min-Ovral, levonorgestrel and ethinyl estradiol. NJBIZ, Paladin Reports 2007 Record Second Quarter Financial Results - Aug 2, 2007 Market Wire (press release)Seasonale TM , (levonorgestrel and ethinyl estradiol 0.15mg/0.03 mg tablets), is a safe and effective contraceptive option for women, striking a balance Agile Therapeutics Appoints Dr. Marie Foegh as Chief Medical Officer - Jul 10, 2007 Earthtimes.orgThis unique patch system delivers a combination of levonorgestrel and ethinyl estradiol. Agile's patch is expected to compete effectively in the $5 billion New birth-control pill to be taken every day - Jun 5, 2007 The Daily Titan,This is because the two main components of the pill, levonorgestrel and ethinyl estradiol, are similar to what is found in most traditional birth-control Exciting Phase III data for schizophrenia drug bifeprunox - May 23, 2007 Pharma Times (subscription),The product is expected to generate sales of around $250 million and will compete with Barr's Seasonale (levonorgestrel and ethinyl estradiol), which reduce Wyeth Contraceptive Approved - May 23, 2007 TheStreet.comLybrel contains levonorgestrel and ethinyl estradiol, which are active ingredients available in other approved oral contraceptives. Year-round contraception safely ends periods - Dec 13, 2006 ReutersNEW YORK (Reuters Health) - Continuous treatment with an oral contraceptive combination of levonorgestrel and ethinyl estradiol (LNG/EE) can safely Wyeth Presents R&D Highlights at Investor Conference Oct 9, 2006 Lybrel(TM) is an investigational oral contraceptive that contains a low dose of levonorgestrel and ethinyl estradiol, a well-studied combination. ... -Drug Newswire (press release), Watson Gets FDA OK for Seasonale Clone Sep 7, 2006 The agency approved Watson's application to sell tablets containing 0.15 milligrams levonorgestrel and ethinyl estradiol 0.03 milligrams, the hormone ... -MSN Money Wyeth Provides Status Update on Triphasil-28 and Alesse Oral ... Aug 3, 2006 NJ, August 2, 2006 — Wyeth (NYSE:WYE) announced that the company has designated both TRIPHASIL®-28 (levonorgestrel and ethinyl estradiol tablets-triphasic ... -PharmaLive.com Wyeth Provides Status Update On TRIPHASIL-28 And ALESSE Oral ... Aug 7, 2006 Wyeth (NYSE:WYE) announced that the company has designated both TRIPHASIL®-28 (levonorgestrel and ethinyl estradiol tablets-triphasic regimen) and ALESSE ... -Medical News Today Earnings Still On Radar; Cisco To Headline Week's Earnings Aug 7, 2006 During the quarter, the company received FDA approval for its new drug application for levonorgestrel and ethinyl estradiol tablets, a generic version of ... -Trading Markets Barr Pulls Lo Seasonale Filing Apr 6, 2006 Seasonique requires women to take a pill combining levonorgestrel and ethinyl estradiol for 84 consecutive days, followed by seven days of ethinyl estradiol. ... - TheStreet.com Seasonique Won't Need New Data Mar 17, 2006 31. The Seasonale treatment includes a combination pill of the drugs levonorgestrel and ethinyl estradiol for 84 days, then a placebo for 7 days. ... - TheStreet.com : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |